Suppr超能文献

钙凝聚的 LABL-TAT 复合物能有效地将基因递送到表达 ICAM-1 的细胞。

Calcium condensed LABL-TAT complexes effectively target gene delivery to ICAM-1 expressing cells.

机构信息

Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047, USA.

出版信息

Mol Pharm. 2011 Jun 6;8(3):788-98. doi: 10.1021/mp100393j. Epub 2011 Apr 22.

Abstract

Targeted gene delivery using nonviral vectors is a highly touted scheme to reduce the potential for toxic or immunological side effects by reducing dose. In previous reports, TAT polyplexes with DNA have shown relatively poor gene delivery. The transfection efficiency has been enhanced by condensing TAT/DNA complexes to a small particle size using calcium. To explore the targetability of these condensed TAT complexes, LABL peptide targeting intercellular cell-adhesion molecule-1 (ICAM-1) was conjugated to TAT peptide using a polyethylene glycol (PEG) spacer. PEGylation reduced the transfection efficiency of TAT, but TAT complexes targeting ICAM-1 expressing cells regained much of the lost transfection efficiency. Targeted block peptides properly formulated with calcium offer promise for gene delivery to ICAM-1 expressing cells at sites of injury or inflammation.

摘要

利用非病毒载体进行靶向基因传递是一种备受推崇的方案,通过降低剂量来减少潜在的毒性或免疫副作用。在以前的报告中,TAT 多聚物与 DNA 的结合显示出相对较差的基因传递效率。通过使用钙离子将 TAT/DNA 复合物凝聚成小颗粒大小,可以提高转染效率。为了探索这些凝聚的 TAT 复合物的靶向性,LABL 肽靶向细胞间黏附分子-1(ICAM-1)被使用聚乙二醇(PEG)间隔物连接到 TAT 肽上。PEGylation 降低了 TAT 的转染效率,但靶向表达 ICAM-1 的细胞的 TAT 复合物恢复了大部分丢失的转染效率。与钙正确配方的靶向阻断肽为在损伤或炎症部位向表达 ICAM-1 的细胞输送基因提供了希望。

相似文献

引用本文的文献

1
Biomimetic nanomedicines for precise atherosclerosis theranostics.用于精准动脉粥样硬化诊疗的仿生纳米药物
Acta Pharm Sin B. 2023 Nov;13(11):4442-4460. doi: 10.1016/j.apsb.2022.11.014. Epub 2022 Nov 15.
4
Vascular Nanomedicine: Current Status, Opportunities, and Challenges.血管纳米医学:现状、机遇与挑战
Semin Thromb Hemost. 2020 Jul;46(5):524-544. doi: 10.1055/s-0039-1692395. Epub 2019 Jun 14.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验